Product nameAnti-LZP antibody [EPR9348]
See all LZP primary antibodies
DescriptionRabbit monoclonal [EPR9348] to LZP
Tested applicationsSuitable for: WB, ICC/IFmore details
Unsuitable for: IHC-P or IP
Species reactivityReacts with: Mouse, Human
Synthetic peptide within Human LZP aa 1-100. The exact sequence is proprietary.
- Human fetal liver and Human plasma lysates.
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
This product was previously labelled as OIT3
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.
This product is a recombinant rabbit monoclonal antibody.
Storage instructionsShipped at 4°C. Store at -20ºC.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab139190 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Predicted molecular weight: 60 kDa.|
|ICC/IF||1/100 - 1/250.|
RelevanceLZP contains one EGF-like domain and one ZP domain. It may be involved in hepatocellular function and development. LZP is liver-specific and is expressed only in the hepatocytes; down-regulated in hepatocellular carcinoma (HCC) and HCC cell lines. There are two named isoforms.
Cellular localizationNucleus envelope. Can be secreted into blood.
- Liver specific zona pellucida domain containing protein antibody
- Liver specific ZP domain containing protein antibody
- LZP antibody
- Oncoprotein induced transcript 3 antibody
ab139190 has not yet been referenced specifically in any publications.